Seattle Children’s Hospital
Date of Award
10.16.2017
Program
Type 1 Diabetes, Prevent & Delay
Amount
$2,031,407
Term of Grant
33 months
Project Title
Development of antigen-specific enhanced T-reg therapy in T1D
Project Description
Funds support a work into a preclinical proof-of-principle for an engineered targeted Treg cell therapy to treat type 1 diabetes.